At this time, posts about Cellma Therapeutics are rapidly increasing on portals and securities communities, while foreign investors are tentatively reported to have net sold 13,292 shares today. Cellma Therapeutics is known as a company distributing gift certificate discounts and dental materials.


As of 12:30 PM on the 30th, the stock price of Cellma Therapeutics is 8,590 KRW, up 5.27% from the previous day, with a trading volume of 9,190,472 shares, which is about 81.49% of the 5-day average trading volume. On December 28th, Cellma Therapeutics was an issue in the market for being "strong due to news of the spread of a variant virus."


In addition to Cellma Therapeutics, posts by investors are also rapidly increasing for Wijewik Studio (299900), Samsung Pharmaceutical (001360), and Hanmi Pharmaceutical (128940).



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing